S&P 500 — US Large Cap Index
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico MarketThe FTSE 100 was flat to slightly higher on Tuesday, attempting to stabilize after ending the previous session down 0.3%. Gains were led by the healthcare sector, where sentiment improved following positive industry news. Novo Nordisk shares rallied after the company received US approval to sell an oral version of its blockbuster obesity drug Wegovy, lifting confidence across the sector. As a result, AstraZeneca rose about 0.7% and GlaxoSmithKline also traded higher, providing support to the index. However, advances were capped by weakness in other heavyweight sectors. Energy stocks lagged as oil prices softened, leaving BP down 0.4% while Shell hovered near flat. The banking sector also weighed on the market, with shares in HSBC, Barclays, Lloyds Banking Group and NatWest all trading lower.
